Stockreport

IN8bio to Present at TD Cowen 46th Annual Health Care Conference

IN8bio, Inc.  (INAB) 
PDF NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (?d) T cell thera [Read more]